Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2026-02-07 @ 11:24 PM
Study NCT ID:
NCT04135092
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2020-09-04
First Post:
2019-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single Patient Protocol: A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab
Sponsor:
National Institutes of Health Clinical Center (CC)
Organization:
Conditions & Keywords Data
Conditions:
Keywords: